The US market is currently closed. It will re-open at today from 13:30.
OSR Health, Inc., formerly OSR Holdings, Inc., is a healthcare holding company. Its platforms include immuno-oncology, regenerative biologics, noninvasive glucose monitoring and medical device technologies. Its subsidiaries include VAXIMM AG (Vaximm); RMC Co., Ltd. (RMC); Darnatein Co., Ltd. (Darnatein), and Woori IO Co., Ltd. (Woori IO). Its VXM01 is a clinical stage VEGFR-2 inhibitor with pre-clinically proven anti-angiogenic activity and encouraging Phase 1/2 safety profile in pancreatic cancer and GBM. Its Darnatein platform is a synthetic biology platform employing AI to generate hybrid versions of endogenous proteins. Lead asset DRT-101 is engineered to function as a BMP super-agonist for joint cartilage regeneration, targeting OA with huge unmet medical needs and potential as a DMOAD. RMC is engaged in medical device distribution business that is also evolving into fourth-party logistics (4PL), offering bundled import licensing, regulatory, and logistics services.
Health
Sector
Freetrade is your gateway to commission-free investing. Join over 1.6 million users using the Best online trading platform, as voted at the British Bank Awards for six years running.
Freetrade does not provide investment advice and individual investors should make their own decisions or seek independent advice. The value of investments can go down as well as up and you may receive back less than your original investment. Past performance is not a reliable indicator of future returns. Freetrade is a trading name of Freetrade Limited, which is a member firm of the London Stock Exchange and is authorised and regulated by the Financial Conduct Authority. Registered in England and Wales (no. 09797821).
© 2026 Freetrade, All rights reserved. The Apple logo is a trademark of Apple Inc. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.
